BNTC vs JCI · $388.7M cap vs P/E 44, rev $23.60B
Benitec Biopharma Ltd ADR (BNTC) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Benitec Biopharma Ltd ADR (BNTC) is a biotechnology company listed on NASDAQ.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported BNTC revenue for 2026-03-31 was $0. Net income was -$32.7M. BNTC currently screens at market cap $388.7M.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
BNTC currently screens at market cap $388.7M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the BNTC and JCI stock pages for the full models.
Not investment advice.